首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   18534篇
  免费   1097篇
  国内免费   485篇
耳鼻咽喉   450篇
儿科学   683篇
妇产科学   82篇
基础医学   835篇
口腔科学   18篇
临床医学   2231篇
内科学   5637篇
皮肤病学   20篇
神经病学   1040篇
特种医学   1567篇
外科学   4131篇
综合类   2169篇
现状与发展   2篇
预防医学   276篇
眼科学   105篇
药学   558篇
  7篇
中国医学   152篇
肿瘤学   153篇
  2024年   50篇
  2023年   333篇
  2022年   620篇
  2021年   849篇
  2020年   788篇
  2019年   721篇
  2018年   742篇
  2017年   534篇
  2016年   579篇
  2015年   644篇
  2014年   1293篇
  2013年   1213篇
  2012年   895篇
  2011年   1092篇
  2010年   860篇
  2009年   832篇
  2008年   842篇
  2007年   876篇
  2006年   799篇
  2005年   668篇
  2004年   563篇
  2003年   479篇
  2002年   418篇
  2001年   354篇
  2000年   331篇
  1999年   291篇
  1998年   262篇
  1997年   234篇
  1996年   199篇
  1995年   204篇
  1994年   186篇
  1993年   171篇
  1992年   161篇
  1991年   125篇
  1990年   111篇
  1989年   96篇
  1988年   84篇
  1987年   76篇
  1986年   68篇
  1985年   77篇
  1984年   66篇
  1983年   28篇
  1982年   74篇
  1981年   52篇
  1980年   41篇
  1979年   36篇
  1978年   30篇
  1977年   11篇
  1976年   17篇
  1975年   14篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
目的:探讨颅内动脉狭窄血管内球囊支架成形术的可行性、安全性及其疗效。方法:17例患者术前3天给予阿司匹林300mg/天和噻氯吡啶250mg/天,6F(Envoy)导引导管放置到颈内动脉远段或椎动脉近颅底段,造影获得工作位,评价血管狭窄程度:狭窄率=(1-狭窄处管径/狭窄远端管径)×100%,微导丝在路途导引下通过颅内动脉狭窄段,向远端直至P2或M2段,确保足够的支撑力。选择支架大小的依据为狭窄远端正常血管的直径,导丝引导下支架通过狭窄部位,造影确定支架位置正确,充盈球囊至5~6大气压,支架释放后造影确认展开良好,回撤球囊,无并发症,操作完毕。随访3~10月。结果:17例患者颅内动脉狭窄处植入支架,技术成功100%,造影显示狭窄由术前(78.3±12.9)%降至术后(6.8±7.3)%,狭窄的动脉管径恢复,短期随访(3~10个月)显示很好临床效果。术中出现一例蛛网膜下腔少量出血(SAH),对症治疗痊愈。6例随访造影未见血管再狭窄。结论:颅内动脉狭窄支架植入增加血管内径,改善血流量,减轻临床症状,是一种安全、可行有效的治疗方法。  相似文献   
122.
Objective: Severe atherosclerosis of the ascending aorta and arch frequently causes difficulties during heart operations, hindering surgical manoeuvres and potentially leading to systemic embolism. The aim of our study was to assess the safety and effectiveness of replacing the atherosclerotic ascending aorta in this setting. Methods: Aortic atherosclerosis was characterized by epiaortic ultrasonographic scanning in 90.1% of 1927 consecutive adult patients undergoing cardiac operations, and by computed tomographic chest scanning in selected cases. Thirty-six of the 152 patients requiring major derangements from our standard practice due to aortic atherosclerosis underwent replacement of the ascending aorta and constitute the study group. Replacement of the aorta was extended to the arch in 13 cases (36.1%). It was associated with single or multiple valve surgery in 34 patients (94.4%) and with coronary revascularization in 30 (83.3%). Two patients (5.6%) underwent coronary bypass grafting without valve surgery. A cryoablation procedure was associated in three patients with permanent atrial fibrillation. Deep hypothermic circulatory arrest was employed in 34 patients (94.4%), while proximal aortic disease allowed conventional distal crossclamping in 2 cases. The risk of operative mortality was estimated by the logistic EuroSCORE both with and withholding the variable ‘surgery of the thoracic aorta’. All survivors were followed-up for 1–41 months (16 ± 12). Results: Two patients died in the hospital (5.6%) and two during follow-up, for a cumulative survival of 91.3% and 85.6% at 1 and 3 years, respectively (hospital deaths included). The hospital death rate compared favourably with the expected estimates of 25.5% (p < 0.05) and 10.3% (p = 0.67) obtained by the EuroSCORE full model and without ‘aortic surgery’, respectively. In-hospital adverse neurologic events occurred in six patients (16.7%), including stroke in one patient (2.8%) and neurocognitive disturbances in five (13.9%), although they were all transient and cleared before discharge. Excess bleeding required re-exploration in four patients (11.1%), and one more patient underwent emergency grafting for acute postoperative coronary occlusion. Ten patients (38.5%) were intubated for longer than 24 h. Conclusion: Despite significant perioperative morbidity, replacement of the severely atherosclerotic aorta is worth consideration to avert expectedly higher death and stroke rates.  相似文献   
123.
Aortic stent graft infection is rare and there are no reported cases of seeded peripheral mycotic aneurysms complicating this condition. We describe the case of a 54 year old man who developed a late stent graft infection at three years, resulting in the peripheral seeding of three mycotic aneurysms with two incidents of rupture. He was successfully treated with extra-anatomic bypass of the aorta and both surgical and endovascular repair of his peripherally seeded mycotic aneurysms.  相似文献   
124.
颈动脉支架置入术治疗颈动脉狭窄   总被引:23,自引:2,他引:21  
颈动脉支架置入术(CS)作为一种治疗颈动脉狭窄(CAS)的新方法,与传统的颈动脉内膜剥离术相比较,具有易操作、创伤小、并发症低等优点,作者就CS的现状、操作方法及并发症处理作一综述。  相似文献   
125.
滕乐群  沈晨阳 《中国卒中杂志》2007,15(10):1128-1133
颈动脉狭窄会导致患者远期认知功能下降,而既往研究表明颈动脉内膜剥脱术和支架
置入术作为治疗颈动脉狭窄的主要术式,可以改善患者的认知功能,尤其是执行能力等特定领域的
认知水平。进一步研究发现颈动脉血管重建术中栓子的形成,术后脑血流灌注提高,以及神经代谢
水平等改变可能在机制上解释颈动脉重建术后认知功能的变化;此外,围术期炎症反应,血脂水平,
以及基因易感性等都是术后远期认知功能结局的临床预测因素,以上因素对于提高颈动脉狭窄患者
的生活质量、治疗术式的优化具有重要临床意义。  相似文献   
126.
治疗完全型大动脉错位伴室间隔缺损、肺动脉狭窄(TGA/VSD,PS)的手术方式有Rastelli手术、Lecompte手术、Nikaidoh手术、Yamagishi手术以及动脉转位 左心室流出道扩大术等多种术式,Rastelli手术和Lecompte手术损伤小,但远期并发症多;Nikaidoh手术和Yamagishi手术解剖纠治完全,但手术损伤大;动脉转位术 左心室流出道扩大术适应证相对较狭窄。因此,在TGA/VSD,PS的外科治疗上,应根据患者的自身情况和手术指征采取不同的手术方法。现对上述手术术式的优缺点、适应证、禁忌证、疗效和展望进行综述。  相似文献   
127.
Abstract The aim of this study was to evaluate the short- to medium-term results (up to 2 years) of conservative and surgical treatments of patients with symptomatic lumbar stenosis. To our knowledge, no previous study has provided strict indications for conservative or surgical treatment. We retrospectively studied 184 patients, who were divided into 3 groups according to JOA (Japanese Orthopaedic Association) score. A cutoff JOA score was arbitrarily fixed at 7. Patients with a score ≤7 (n=12; group A) underwent surgery, while patients with a score >7 (n=172) were conservatively treated. Group A included patients surgically treated within two months from diagnosis. Group B consisted of 144 patients who received conservative treatment, while group C (28 patients) represented patients who underwent surgery after a period of failed conservative treatment. The outcomes of surgical and conservative treatments were evaluated after 12 and 24 months, and were rated as satisfactory, not totally satisfactory, not satisfactory or totally unsatisfactory. Conservative treatment consisted of physical, orthotic and drug therapy, whereas surgical treatment included spinal decompression and instrumentation (if indicated), either rigidly or dynamically performed. Surgery was indicated in 22% of all patients and we obtained excellent results in 85% of them. Operative treatment provides excellent results for patients with severe clinical presentation (JOA score ≤7), while individuals with mild to moderate spinal stenosis (JOA score >7) should receive conservative treatment.  相似文献   
128.
目的定量评估64层螺旋CT(MSCT)与DSA2种成像方法显示冠状动脉狭窄及支架内再狭窄的能力和可靠性。方法应用心脏动态体模,设定心率为0、50、70、90次/min,对内径3mm的模拟冠状动脉(内设25%、50%、75%3段狭窄)及内径4mm的模拟带支架冠状动脉(支架段内设50%、75%2段狭窄)分别进行MSCT与DSA成像,将MSCT与DSA对应数据进行分析。结果(1)MSCT对25%、50%、75%3段狭窄的平均测量值为(30.0±1.4)%、(49.5±1.3)%、(72.9±3.9)%(P值分别为0.005、0.531、0.369);DSA分别为(24.8±2.0)%、(48.2±2.1)%、(75.3±2.4)%(P值分别为0.883、0.180、0.796)。(2)MSCT图像伪影随心率增快而增加,心率≥70次/min影响变明显;DSA不受心率影响,所有心率下都可清晰地显示狭窄程度,无伪影。(3)MSCT与DSA测量血管狭窄程度有较好的相关性(r=0.995,P=0.000)。(4)MSCT可同时显示支架及支架内狭窄,但显示支架内狭窄能力有限,对50%狭窄分别显示为(46.4±4.5)%(心率为0)和(43.6±5.7)%(心率为50次/min),与标准值(50%)相比,差异有统计学意义(P〈0.05)。DSA可清晰显示支架内狭窄,但不能很好显示支架形态。结论(1)MSCT与DSA评价冠状动脉狭窄结果可靠,MSCT受心率的影响大,时间分辨率有待提高,作为排除性诊断有很高的临床应用价值;MSCT对于支架内再狭窄的判断尚有一定局限性,但在管径较粗和低心率条件下评价支架内再狭窄有一定价值。  相似文献   
129.
Objective To analyze the risk factors of the postoperative mid- and long-term aortic valvular regurgitation after ROSS procedure(pulmanary valve homograft transplantation). Methods Between March 1998 and July 2007,47 patients[25male, 22 female, mean age (13.31±5.79) years, ronge 1-34 years] with aortic valvular disease underwent the Ross procedure at our insti tution. There were 6 patients suffering fron rheumatic heart disease and 41 patients suffering from congenital heart disease. The aver age aortic blood flow velocity was (4.67±3.47) m/s, the average pressure gradient across aortic valve (88.26±58.06)mm Hg, LVEDD (45.53 ±10.78) mm, EF 0.69±0.08. All the patients were followed up in out-patient departement by ultrasonic cardio gram. Multiple logistic regression analysis was performed to find out the risk factors of the postive aortic valvular regurgitation. Results There was no poetoperative death in hospital. The mean follow-up periods was (36.15±22.1) months, rasnge from 12 to 110 months and none long-dated death. Compared with the data recorded in hospital, the diamenters of the aortic sinus and aortic annu lus enlarged significantly, respectively from (26.16±5.10) mm to (32.37±6.84) tam and from (19.41 ~3.98) mm to (23.45± 5.86) mm. The average flow velocity d the homograft (new aortic valve) was(1.39±0.48) m/s, graclient pressure (8.17+6.16) mm Hg. Mild aortic regurgitstion was present in 5 patients (10.6%), moderate aortic tegmgitafion in 2 pmieats (4.3%) and aevere aortic regurgitation in 1 petient (2.1%). The rate of free from regurgitation was 82.9%. Multiple logistic analyses identified the per esence of bicuspid aortic valve, enlargement of aortic annulus and age above 14 years as the risk factors for posterative aortic regurg itation. Conclusion The Ross procedure is a safe and effective procedure with good clinical results in mid-and long-term follow-up. However, the presence of bicuspid aortic valve, enlargement of aortic annulus and age above 14 years preoperatively were identified as the risk factors for postoperative aortic regurgitation.  相似文献   
130.
目的:探讨大剂量甲基强的松龙(MP)在胸椎管狭窄症患者围手术期应用的效果。方法:84例胸椎管狭窄症患者均行椎板切除减压术,并将其分为2组,A组,围手术期应用大剂量MP组,36例,术中进椎管前静脉给予MP 30mg/kg,15min滴完;术后静脉应用MP(80mg/d)3d。B组,围手术期应用氟美松治疗组,48例,术后静脉应用氟美松(10mg/d)3d。比较两组患者手术前后的神经功能变化情况(JOA评分17分法),并对计量资料行t检验。结果:术前JOA评分A组为8.58±2.62分,B组为9.12±2.81分,两组间无显著性差异(P>0.05)。术后1周时A组为13.65±2.16分,B组为11.12±2.36分;术后3个月时A组为14.11±2.21分,B组为12.62±2.35分,两组间比较均有显著性差异(P<0.05)。B组有9例患者术后即刻出现神经功能障碍加重,而A组未出现类似病例。结论:围手术期应用大剂量MP对胸椎管狭窄症患者的脊髓功能有保护作用。  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号